Non-small cell lung cancer

You have access
Brexpiprazole Reduces Survivin and Reverses EGFR Tyrosine Kinase Inhibitor Resistance in Lung and Pancreatic Cancer
TOMOMI SANOMACHI, SHUHEI SUZUKI, KEITA TOGASHI, SHIZUKA SEINO, TAKASHI YOSHIOKA, CHIFUMI KITANAKA, MASASHI OKADA and MASAHIRO YAMAMOTO

Anticancer Research September 2019, 39 (9) 4817-4828; DOI: https://doi.org/10.21873/anticanres.13667
You have access
Previous Immune Checkpoint Inhibitor Treatment to Increase the Efficacy of Docetaxel and Ramucirumab Combination Chemotherapy
DAIJIRO HARADA, KENJI TAKATA, SHUNTA MORI, TOSHIYUKI KOZUKI, YOSHIKA TAKECHI, SATOKO MORIKI, YUMI ASAKURA, TAKAYUKI OHNO and NAOYUKI NOGAMI

Anticancer Research September 2019, 39 (9) 4987-4993; DOI: https://doi.org/10.21873/anticanres.13688
You have access
Prognostic Significance of IGF-1 Signalling Pathway in Patients With Advanced Non-small Cell Lung Cancer
IOANNIS KOTSANTIS, PANAGIOTA ECONOMOPOULOU, AMANDA PSYRRI, EIRINI MARATOU, DIMITRIOS PECTASIDES, HELEN GOGAS, NIKOLAOS KENTEPOZIDIS, GIANNIS MOUNTZIOS, GEORGE DIMITRIADIS and STAVROULA GIANNOULI

Anticancer Research August 2019, 39 (8) 4185-4190; DOI: https://doi.org/10.21873/anticanres.13578
You have access
Patterns of End-of-Life Oncologic Care for Stage IV Non-small Cell Lung Cancer in the United States
WAQAR HAQUE, VIVEK VERMA, E. BRIAN BUTLER and BIN S. TEH

Anticancer Research June 2019, 39 (6) 3137-3140; DOI: https://doi.org/10.21873/anticanres.13450
You have access
ECCR1 and NFKB2 Polymorphisms as Potential Biomarkers of Non-small Cell Lung Cancer in a Polish Population
MONIKA CHASZCZEWSKA-MARKOWSKA, MONIKA KOSACKA, AGNIESZKA CHRYPLEWICZ, TOMASZ DYŁA, ANNA BRZECKA and KATARZYNA BOGUNIA-KUBIK

Anticancer Research June 2019, 39 (6) 3269-3272; DOI: https://doi.org/10.21873/anticanres.13469
You have access
Investigation of Caspase 9 Gene Polymorphism in Patients With Non-small Cell Lung Cancer
SINA ERCAN, SIBEL ARINC, SEDA GULEC YILMAZ, CIGDEM ALTUNOK, FERIDE YAMAN and TURGAY ISBIR

Anticancer Research May 2019, 39 (5) 2437-2441; DOI: https://doi.org/10.21873/anticanres.13361
You have access
Ganetespib in Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-resistant Non-small Cell Lung Cancer
EISUKE KURIHARA, KAZUHIKO SHIEN, HIDEJIRO TORIGOE, TATSUAKI TAKEDA, YUTA TAKAHASHI, YUSUKE OGOSHI, TAKAHIRO YOSHIOKA, KEI NAMBA, HIROKI SATO, KEN SUZAWA, HIROMASA YAMAMOTO, JUNICHI SOH, MIKIO OKAZAKI, TADAHIKO SHIEN, SHUTA TOMIDA and SHINICHI TOYOOKA

Anticancer Research April 2019, 39 (4) 1767-1775; DOI: https://doi.org/10.21873/anticanres.13283
You have access
Mifepristone Extends Both Length and Quality of Life in a Patient With Advanced Non-small Cell Lung Cancer that Has Progressed Despite Chemotherapy and a Check-point Inhibitor
JEROME H. CHECK, DIANE CHECK and TRINA PORETTA

Anticancer Research April 2019, 39 (4) 1923-1926; DOI: https://doi.org/10.21873/anticanres.13301
You have access
Association of Low Body Mass Index With Poor Clinical Outcomes After Resection of Non-small Cell Lung Cancer
KAZUKI TAKADA, MOTOTSUGU SHIMOKAWA, TAKAKI AKAMINE, YUKI ONO, AKIRA HARO, ATSUSHI OSOEGAWA, TETSUZO TAGAWA and MASAKI MORI

Anticancer Research April 2019, 39 (4) 1987-1996; DOI: https://doi.org/10.21873/anticanres.13309
You have access
Postoperative C-reactive Protein Is a Predictive Biomarker for Survival After Non-small Cell Lung Cancer Resection
SHUICHI SHINOHARA, RYO OTSUKI, TAKAMITSU ONITSUKA, KAZUHIKO MACHIDA, MASAKI MATSUO, MAKOTO NAKAGAWA and MASAKAZU SUGAYA

Anticancer Research April 2019, 39 (4) 2193-2198; DOI: https://doi.org/10.21873/anticanres.13334

Main menu

User menu

Search

Non-small cell lung cancer

Pages